• Research & Development

  Cancer marker NEDD9 could be a therapeutic target for PAH, study

  Posted by Pulmonary Hypertension News Moderator on June 22, 2018 at 8:56 am

  A cancer marker called NEDD9 is a critical mediator of pulmonary arterial hypertension (PAH) and could be a therapeutic target, according to new research.

  Read about about this new study in: Cancer Marker NEDD9 Could Be a Therapeutic Target for PAH, Study Suggests

  Have you heard of this news? What are your thoughts?

  Pulmonary Hypertension News Moderator replied 5 years, 11 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply